Companies in #Hereditary Hemorrhagic Telangiectasia
Found 1 company operating in this sector.
Vaderis Therapeutics
PrivateClinical-stage biotech developing treatments for rare orphan diseases caused by vascular malformations. Lead program for HHT (Hereditary Hemorrhagic Telangiectasia). FDA Fast Track designation.